New Hampshireclassifying xylazine as a schedule III controlled drug.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Apr 23Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55Latest
- Apr 15Minority Committee Report: Ought to Pass
- Apr 15Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC)Minor
- Apr 8Executive Session: 04/14/2026 01:00 pm GP 153
- Apr 1Full Committee Work Session: 04/07/2026 01:00 pm GP 153
- Mar 18Public Hearing: 03/31/2026 01:30 pm GP 153
- Mar 16Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8 P. 114Minor
- Mar 5Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026; SJ 5Passed Senate
- Mar 5Committee Amendment # 2026-0842s, AA, VV; 03/05/2026; SJ 5
- Feb 20Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8Minor
- Feb 5Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A
- 2025
- Nov 21Introduced 01/07/2026 and Referred to Judiciary; SJ 1Introduced